Scott R Lambert Selected Research

Aphakia

1/2022	The accuracy of intraocular lens calculation varies by age in the Infant Aphakia Treatment Study.
2/2021	The Myopic Shift in Aphakic Eyes in the Infant Aphakia Treatment Study After 10 Years of Follow-up.
1/2021	Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.
1/2021	Outcomes of Bilateral Cataract Surgery in Infants 7 to 24 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry.
1/2021	Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study.
11/2020	Complications at 10 Years of Follow-up in the Infant Aphakia Treatment Study.
10/2020	Rate of ocular trauma in children operated on for unilateral cataract in infancy-data from the Infant Aphakia Treatment Study.
1/2020	Long-term Effect of Intraocular Lens vs Contact Lens Correction on Visual Acuity After Cataract Surgery During Infancy: A Randomized Clinical Trial.
10/2019	Intraocular Lens Implantation during Early Childhood: A Report by the American Academy of Ophthalmology.
1/2019	Spectacle Adherence Among Four-Year-Old Children in the Infant Aphakia Treatment Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott R Lambert Research Topics

Disease

44	Aphakia 01/2022 - 12/2003
43	Cataract (Cataracts) 09/2022 - 12/2003
13	Strabismus (Squint) 09/2022 - 12/2003
6	Glaucoma 01/2021 - 01/2004
6	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020 - 04/2002
5	Amblyopia (Lazy Eye) 09/2022 - 12/2006
5	Refractive Errors (Refractive Error) 10/2019 - 04/2002
5	Astigmatism 11/2017 - 08/2004
3	Wounds and Injuries (Trauma) 09/2013 - 08/2004
3	Esotropia (Esophoria) 01/2013 - 02/2003
2	Uveitis 01/2022 - 09/2011
2	Anterior Uveitis 01/2022 - 01/2019
2	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 06/2014
2	Keratitis 01/2019 - 01/2018
2	Corneal Injuries 01/2018 - 07/2017
2	Myopia 12/2017 - 04/2012
2	Exotropia (Exophoria) 01/2013 - 12/2012
2	Neoplasms (Cancer) 10/2009 - 01/2005
1	Blindness (Hysterical Blindness) 01/2022
1	Lacrimal Duct Obstruction 12/2021
1	Ectopia Lentis 11/2021
1	Diplopia (Double Vision) 01/2019
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2018
1	Hyperemia 01/2018
1	Corneal Edema 01/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Anisometropia 08/2017
1	Hemorrhage 04/2016
1	Retinal Hemorrhage 04/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016
1	Atrophy 01/2016
1	Intraoperative Complications 11/2014
1	Inflammation (Inflammations) 09/2013
1	Fibrosis (Cirrhosis) 10/2011
1	Vision Disorders (Hemeralopia) 09/2011
1	Endophthalmitis (Ophthalmia) 04/2011
1	Substance-Related Disorders (Drug Abuse) 08/2010
1	Urinary Tract Infections (Urinary Tract Infection) 08/2010
1	Eye Diseases (Eye Disease) 01/2010
1	Retinoblastoma (Glioblastoma, Retinal) 10/2009
1	Neoplasm Metastasis (Metastasis) 10/2009
1	Vitreous Hemorrhage 10/2009
1	Coloboma (Colobomas) 05/2003

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 01/2022 - 06/2012
5	Dihydrotachysterol (AT 10)IBA 01/2021 - 01/2019
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2017 - 07/2012
2	Silicone Elastomers (SE 30)IBA 02/2021 - 01/2018
2	SteroidsIBA 10/2018 - 01/2018
2	Botulinum Toxins (Botulinum Toxin)IBA 02/2015 - 01/2013
1	ametantrone (HAQ)IBA 01/2022
1	HydrogelsIBA 02/2021
1	SiliconesIBA 02/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Atropine FDA LinkGeneric 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 11/2015
1	3,4-Dihydroxyphenylacetic AcidIBA 11/2015
1	Homovanillic AcidIBA 11/2015
1	Bevacizumab (Avastin)FDA Link 05/2015
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 09/2013
1	F 7302 (7302)IBA 01/2013
1	Type A Botulinum Toxins (Botox)FDA Link 12/2012
1	Capsules (Microcapsules)IBA 10/2011
1	Complement System Proteins (Complement)IBA 09/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	TenascinIBA 01/2005
1	CollagenIBA 01/2005
1	Aggrecans (Aggrecan)IBA 01/2005
1	BiglycanIBA 01/2005
1	DecorinIBA 01/2005
1	RNA (Ribonucleic Acid)IBA 01/2005
1	boldenone undecylenate (Equipoise)IBA 12/2003

Therapy/Procedure

35	Intraocular Lenses (Intraocular Lens) 01/2022 - 12/2003
34	Contact Lenses 01/2022 - 12/2003
12	Intraocular Lens Implantation 01/2022 - 12/2003
11	Therapeutics 09/2022 - 01/2004
7	Sutures (Suture) 01/2022 - 02/2012
7	Cataract Extraction 01/2021 - 12/2006
4	Eyeglasses (Spectacles) 02/2021 - 02/2003
3	Suture Techniques 01/2022 - 05/2003
3	Lasers (Laser) 01/2017 - 04/2002
3	Vitrectomy 12/2013 - 10/2009
2	Scleral Buckling 01/2019 - 12/2013
2	Lenses 01/2019 - 01/2018
2	Light Coagulation 01/2017 - 05/2015
2	Injections 02/2015 - 12/2012
2	Cryotherapy (Therapy, Cold) 04/2012 - 04/2002
1	Treatment Delay 01/2022
1	Operative Surgical Procedures 12/2021
1	Telescopes 01/2020
1	Cardiopulmonary Resuscitation (CPR) 04/2016
1	Off-Label Use 09/2013
1	Aftercare (After-Treatment) 04/2012
1	General Anesthesia 04/2011
1	Radiotherapy 10/2009
1	Surgical Instruments (Clip) 08/2004